4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow NGM282: new trials by email Literature Review of NGM282 trials Research Report on NGM282
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects Aldafermin - Healthy Male | Phase 1 | Completed | NGM Biopharmaceuticals, Inc | 36 | 2021-04-13 | 2022-01-31 |
| Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function Aldafermin - Impaired Hepatic Function | Phase 1 | Completed | NGM Biopharmaceuticals, Inc | 36 | 2021-04-01 | 2022-01-19 |
| Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals NGM282, Placebo - Functional Constipation | Phase 1 / Phase 2 | Completed | NGM Biopharmaceuticals, Inc | 31 | 2015-12-01 | 2018-03-30 |
| Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants NGM282, Placebo - Diabetes Mellitus | Phase 1 | Completed | NGM Biopharmaceuticals, Inc | 119 | 2013-01-01 | 2013-12-31 |
NGM Biopharmaceuticals, Inc (4)
United States (3) · Australia (1)
Alex M DePaoli, MD (1) · Stephen J Rossi, PharmD (1)